Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cannabis company GW Pharmaceuticals raises $34.5mm in IPO

Executive Summary

British biotechnology company GW Pharmaceuticals, which is developing prescription drugs derived from cannabis, raised gross proceeds of $34.5mm (UK25mm) in an oversubscribed initial public offering of almost 13.7mm ordinary shares on the Alternative Investment Market. It had originally expected to raise UK16mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register